1. Home
  2. UNB vs ALDX Comparison

UNB vs ALDX Comparison

Compare UNB & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Bankshares Inc.

UNB

Union Bankshares Inc.

HOLD

Current Price

$23.26

Market Cap

105.4M

Sector

Finance

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$1.63

Market Cap

101.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNB
ALDX
Founded
1891
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.4M
101.1M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
UNB
ALDX
Price
$23.26
$1.63
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.50
AVG Volume (30 Days)
20.2K
910.3K
Earning Date
04-15-2026
05-01-2026
Dividend Yield
5.76%
N/A
EPS Growth
25.52
40.43
EPS
0.65
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.65
$1.07
52 Week High
$29.49
$6.18

Technical Indicators

Market Signals
Indicator
UNB
ALDX
Relative Strength Index (RSI) 43.63 45.34
Support Level $23.06 $1.49
Resistance Level $24.77 $1.88
Average True Range (ATR) 0.53 0.13
MACD -0.04 0.03
Stochastic Oscillator 23.19 32.94

Price Performance

Historical Comparison
UNB
ALDX

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: